试用视觉搜索
使用图片进行搜索,而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索,请在浏览器中启用相机
English
搜索
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
1920×960
ENDPOINTS NEWS
Michael Ehlers and Romesh Subramanian launch biotech with $50M, sea squirt-inspired RNA-editing tech
2400×1350
ENDPOINTS NEWS
As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff
2400×1350
ENDPOINTS NEWS
In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK ...
1200×802
ENDPOINTS NEWS
FDA leaders Califf and Pazdur dish on accelerated approval reforms, …
2400×1350
ENDPOINTS NEWS
Atlas-backed biotech focused on Huntington’s disease shuts down less th…
2400×1350
ENDPOINTS NEWS
Catalent sells New Jersey plant to Belgian CDMO, plans moving HQ elsewhere – E…
2560×1707
ENDPOINTS NEWS
The election is Tuesday. What’s at stake for the pharma industry?
2400×1350
ENDPOINTS NEWS
Ahead of Novo’s CagriSema readout, Lilly dives back into DACRA
2048×1152
ENDPOINTS NEWS
Ahead of FDA, EMA recommends authorizing new gene therapy treatment for ultra-rare disease
2400×1350
ENDPOINTS NEWS
GSK warns 50+ crowd to ‘wake up’ to viral danger of shingles in latest campaign
2400×1350
ENDPOINTS NEWS
#ESMO22: Outside liver cancer, Keytruda notches key win in neoadjuvant setting but flops in head ...
2400×1350
ENDPOINTS NEWS
Betting on CD47 as others ditch the target, ALX borrows up to $100M to push sole clinical drug ...
2400×1350
ENDPOINTS NEWS
CD28 kills again? Mitch Gold’s plan to make cell therapy 2.0 history crashes after another ...
2560×1708
ENDPOINTS NEWS
Novo Nordisk claims late-stage MASH victory, continuing GLP-…
2400×1350
ENDPOINTS NEWS
Roche says it is undeterred by upcoming biosimilar threat to Vabysmo
2400×1350
ENDPOINTS NEWS
Nektar divests manufacturing site and reagent arm for $90M
2400×1350
ENDPOINTS NEWS
Gilead partners with AI startup Genesis Therapeutics to make small molecule d…
2400×1350
ENDPOINTS NEWS
Not so fast, Teva. Vifor wins a few more years of protection from a potential Velp…
2560×1707
ENDPOINTS NEWS
Incyte adds first Opzelura brand TV commercial, and a famous voice, …
2560×1707
ENDPOINTS NEWS
Eli Lilly inks another obesity pact, doubling down on small Swiss pa…
2400×1350
ENDPOINTS NEWS
Nearly out of cash, a former Sarepta partner asks French courts to oversee re…
2400×1350
ENDPOINTS NEWS
AbbVie’s immunology blockbusters make up for Humira sales drop in Q3
2560×1646
ENDPOINTS NEWS
MASH drug developers chart path forward as more patients use GL…
2400×1350
ENDPOINTS NEWS
Novartis ends mid-stage IPF trial, will keep testing drug in PAH
2400×1350
ENDPOINTS NEWS
Novo Nordisk files 18 lawsuits against GLP-1 compounders in 44 days
2400×1350
ENDPOINTS NEWS
After presiding over stormy years, John McHutchison picks his ‘strategic partner’ to run ...
2400×1350
ENDPOINTS NEWS
FDA partially holds BioNTech’s Phase 3 anti-CTLA-4, company pauses enrollment
2400×1350
ENDPOINTS NEWS
GSK offers glimpse at RSV vaccine in at-risk younger adults before ACIP meeting
2400×1350
ENDPOINTS NEWS
‘Not Today, Flu’: Sanofi enlists Seinfeld star Jason Alexander to boost flu vaccinations this fall
2400×1350
ENDPOINTS NEWS
Exclusive: PhRMA attacks federal government’s response to rebate model for 340B
2400×1350
ENDPOINTS NEWS
Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots
2400×1350
ENDPOINTS NEWS
ICER slightly softens its recommendation on Pfizer’s ATTR-CM drug price
2400×1350
ENDPOINTS NEWS
FDA approves Astellas’ gastric cancer drug Vyloy ahead of schedule
2048×1152
ENDPOINTS NEWS
Merck KGaA’s MilliporeSigma invests $286M to build out biosafety testing – Endpoints News
2400×1350
ENDPOINTS NEWS
Lonnie Moulder’s new biotech play grabs $118M, steering into PhIII and more deals
某些结果已被隐藏,因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
Invisible focusable element for fixing accessibility issue
反馈